No effects of lifelong creatine supplementation on sarcopenia in senescence-accelerated mice (SAMP8). (Q45280328)

11 December 2017

No effects of lifelong creatine supplementation on sarcopenia in senescence-accelerated mice (SAMP8). (English)

1 reference

11 December 2017

1 reference

1

1 reference

11 December 2017

Bert O Eijnde

2

1 reference

PubMed ID

15727953

11 December 2017

Monique Ramaekers

series ordinal

3

1 reference

PubMed ID

15727953

11 December 2017

Peter Hespel

series ordinal

4

1 reference

11 December 2017

22 February 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

11 December 2017

1 reference

11 December 2017

289

1 reference

11 December 2017

2

1 reference

11 December 2017

E272-7

1 reference

Creatine supplementation combined with resistance training in older men.

11 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Creatine supplementation in health and disease: what is the evidence for long-term efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Effects of creatine supplementation and exercise training on fitness in men 55-75 yr old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Creatine supplementation improves muscular performance in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Sarcopenia--consequences, mechanisms, and potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Muscle creatine loading in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Mitochondrial DNA deletion mutations: a causal role in sarcopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Senescence-accelerated mouse (SAM): a biogerontological resource in aging research

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Premature ageing in mice expressing defective mitochondrial DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Invited review: Theories of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00039.2005

10.1152/AJPENDO.00039.2005

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

15727953